Why is Trump pushing Coca-Cola to use cane sugar?
How did inflation affect stock and bond markets today?
What caused Scale AI's recent layoffs after Meta funding?
Why are crypto bills stalling again in the House?
How will firing Fed Chair Powell impact the economy?
Why is ASML's stock tumbling after Q2 earnings?
What led to United Airlines lowering its 2025 profit forecast?
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
cnbc.com/2025/07/16/healthy-returns-chinese-obesity-may-become-a-rival-to-eli-lillys-zepbound-.htmlAn obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki's nonprofit acquires 23andMe.
This story appeared on cnbc.com, 2025-07-16 17:19:24.